{"id":1858,"date":"2013-05-29T17:46:23","date_gmt":"2013-05-29T17:46:23","guid":{"rendered":"https:\/\/www.lymphoma.ca\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/"},"modified":"2013-05-29T17:46:23","modified_gmt":"2013-05-29T17:46:23","slug":"des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules","status":"publish","type":"post","link":"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/","title":{"rendered":"Des provinces canadiennes financent un nouveau traitement pour les patients atteints d\u2019un lymphome non hodgkinien de type indolent (LNHi) et pour ceux atteints d\u2019un lymphome \u00e0 cellules du manteau (LCM)"},"content":{"rendered":"<p>Lymphome Canada se r\u00e9jouit de l\u2019annonce de remboursement faite par les provinces de l\u2019Alberta, de la Saskatchewan et de l\u2019Ontario, qui financeront le m\u00e9dicament Treanda (bendamustine)<br \/>\n<!--more--><\/p>\n<p>Lymphome Canada se r\u00e9jouit de l\u2019annonce de remboursement faite par les provinces de l\u2019Alberta, de la Saskatchewan et de l\u2019Ontario, qui financeront le m\u00e9dicament Treanda (bendamustine) comme nouveau traitement de premi\u00e8re intention du LNHi et du LCM, lorsqu\u2019utilis\u00e9 en association avec le rituximab. Les provinces ont \u00e9galement d\u00e9cid\u00e9 de financer Treanda (bendamustine) dans le traitement du LNHi et du LCM r\u00e9cidivants ou r\u00e9fractaires, comme le recommande le r\u00e9cent processus pancanadien d\u2019examen des m\u00e9dicaments contre le cancer \u2014 le pan-Canadian Oncology Drug Review (pCODR)<sup>(1).<\/sup><\/p>\n<p>Treanda (bendamustine) fait actuellement l\u2019objet d\u2019un remboursement au cas par cas en Colombie-Britannique, au Manitoba et dans les provinces de l\u2019Atlantique. Des annonces de financement officielles devraient \u00eatre faites tr\u00e8s prochainement.<\/p>\n<p>Le moment est venu pour le Qu\u00e9bec d\u2019embo\u00eeter le pas et de financer ce nouveau sch\u00e9ma th\u00e9rapeutique tr\u00e8s attendu et n\u00e9cessaire chez les patients atteints de LNHi et LCM.<\/p>\n<p>1-&nbsp; <a href=\"http:\/\/www.pcodr.ca\/idc\/groups\/pcodr\/documents\/pcodrdocument\/pcodr-treandanhl-fn-rec.pdf\">http:\/\/www.pcodr.ca\/idc\/groups\/pcodr\/documents\/pcodrdocument\/pcodr-treandanhl-fn-rec.pdf<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lymphome Canada se r\u00e9jouit de l\u2019annonce de remboursement faite par les provinces de l\u2019Alberta, de la Saskatchewan et de l\u2019Ontario, qui financeront le m\u00e9dicament Treanda (bendamustine)<\/p>\n","protected":false},"author":1,"featured_media":1771,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[17],"tags":[],"class_list":{"0":"post-1858","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-recherche"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Des provinces canadiennes financent un nouveau traitement pour les patients atteints d\u2019un lymphome non hodgkinien de type indolent (LNHi) et pour ceux atteints d\u2019un lymphome \u00e0 cellules du manteau (LCM) - Lymphoma Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Des provinces canadiennes financent un nouveau traitement pour les patients atteints d\u2019un lymphome non hodgkinien de type indolent (LNHi) et pour ceux atteints d\u2019un lymphome \u00e0 cellules du manteau (LCM) - Lymphoma Canada\" \/>\n<meta property=\"og:description\" content=\"Lymphome Canada se r\u00e9jouit de l\u2019annonce de remboursement faite par les provinces de l\u2019Alberta, de la Saskatchewan et de l\u2019Ontario, qui financeront le m\u00e9dicament Treanda (bendamustine)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/\" \/>\n<meta property=\"og:site_name\" content=\"Lymphoma Canada\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LymphomaCanada\" \/>\n<meta property=\"article:published_time\" content=\"2013-05-29T17:46:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@lymphomacanada\" \/>\n<meta name=\"twitter:site\" content=\"@lymphomacanada\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4\"},\"headline\":\"Des provinces canadiennes financent un nouveau traitement pour les patients atteints d\u2019un lymphome non hodgkinien de type indolent (LNHi) et pour ceux atteints d\u2019un lymphome \u00e0 cellules du manteau (LCM)\",\"datePublished\":\"2013-05-29T17:46:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/\"},\"wordCount\":241,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg\",\"articleSection\":[\"Recherche\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/\",\"name\":\"Des provinces canadiennes financent un nouveau traitement pour les patients atteints d\u2019un lymphome non hodgkinien de type indolent (LNHi) et pour ceux atteints d\u2019un lymphome \u00e0 cellules du manteau (LCM) - Lymphoma Canada\",\"isPartOf\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg\",\"datePublished\":\"2013-05-29T17:46:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/#primaryimage\",\"url\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg\",\"contentUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg\",\"width\":700,\"height\":300,\"caption\":\"masthead_ph_shadows\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.lymphoma.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Des provinces canadiennes financent un nouveau traitement pour les patients atteints d\u2019un lymphome non hodgkinien de type indolent (LNHi) et pour ceux atteints d\u2019un lymphome \u00e0 cellules du manteau (LCM)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#website\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/\",\"name\":\"Lymphoma Canada\",\"description\":\"Information. Help. Hope.\",\"publisher\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lymphoma.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\",\"name\":\"Lymphoma Canada\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg\",\"contentUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg\",\"width\":343,\"height\":343,\"caption\":\"Lymphoma Canada\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/LymphomaCanada\",\"https:\/\/x.com\/lymphomacanada\",\"https:\/\/www.linkedin.com\/company\/lymphoma-canada\/\",\"http:\/\/instagram.com\/lymphomacanada\",\"http:\/\/www.youtube.com\/user\/LymphomaTV\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/www.lymphoma.ca\/fr\/author\/erezz_oxmaxp0p\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Des provinces canadiennes financent un nouveau traitement pour les patients atteints d\u2019un lymphome non hodgkinien de type indolent (LNHi) et pour ceux atteints d\u2019un lymphome \u00e0 cellules du manteau (LCM) - Lymphoma Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/","og_locale":"fr_FR","og_type":"article","og_title":"Des provinces canadiennes financent un nouveau traitement pour les patients atteints d\u2019un lymphome non hodgkinien de type indolent (LNHi) et pour ceux atteints d\u2019un lymphome \u00e0 cellules du manteau (LCM) - Lymphoma Canada","og_description":"Lymphome Canada se r\u00e9jouit de l\u2019annonce de remboursement faite par les provinces de l\u2019Alberta, de la Saskatchewan et de l\u2019Ontario, qui financeront le m\u00e9dicament Treanda (bendamustine)","og_url":"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/","og_site_name":"Lymphoma Canada","article_publisher":"https:\/\/www.facebook.com\/LymphomaCanada","article_published_time":"2013-05-29T17:46:23+00:00","og_image":[{"width":700,"height":300,"url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@lymphomacanada","twitter_site":"@lymphomacanada","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/#article","isPartOf":{"@id":"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/"},"author":{"name":"admin","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4"},"headline":"Des provinces canadiennes financent un nouveau traitement pour les patients atteints d\u2019un lymphome non hodgkinien de type indolent (LNHi) et pour ceux atteints d\u2019un lymphome \u00e0 cellules du manteau (LCM)","datePublished":"2013-05-29T17:46:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/"},"wordCount":241,"commentCount":0,"publisher":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#organization"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg","articleSection":["Recherche"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/","url":"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/","name":"Des provinces canadiennes financent un nouveau traitement pour les patients atteints d\u2019un lymphome non hodgkinien de type indolent (LNHi) et pour ceux atteints d\u2019un lymphome \u00e0 cellules du manteau (LCM) - Lymphoma Canada","isPartOf":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/#primaryimage"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg","datePublished":"2013-05-29T17:46:23+00:00","breadcrumb":{"@id":"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/#primaryimage","url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg","contentUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg","width":700,"height":300,"caption":"masthead_ph_shadows"},{"@type":"BreadcrumbList","@id":"https:\/\/www.lymphoma.ca\/fr\/des-provinces-canadiennes-financent-un-nouveau-traitement-pour-les-patients-atteints-dun-lymphome-non-hodgkinien-de-type-indolent-lnhi-et-pour-ceux-atteints-dun-lymphome-a-cellules\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.lymphoma.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Des provinces canadiennes financent un nouveau traitement pour les patients atteints d\u2019un lymphome non hodgkinien de type indolent (LNHi) et pour ceux atteints d\u2019un lymphome \u00e0 cellules du manteau (LCM)"}]},{"@type":"WebSite","@id":"https:\/\/www.lymphoma.ca\/fr\/#website","url":"https:\/\/www.lymphoma.ca\/fr\/","name":"Lymphoma Canada","description":"Information. Help. Hope.","publisher":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lymphoma.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.lymphoma.ca\/fr\/#organization","name":"Lymphoma Canada","url":"https:\/\/www.lymphoma.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg","contentUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg","width":343,"height":343,"caption":"Lymphoma Canada"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LymphomaCanada","https:\/\/x.com\/lymphomacanada","https:\/\/www.linkedin.com\/company\/lymphoma-canada\/","http:\/\/instagram.com\/lymphomacanada","http:\/\/www.youtube.com\/user\/LymphomaTV"]},{"@type":"Person","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4","name":"admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/www.lymphoma.ca\/fr\/author\/erezz_oxmaxp0p\/"}]}},"_links":{"self":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/1858","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/comments?post=1858"}],"version-history":[{"count":0,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/1858\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/media\/1771"}],"wp:attachment":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/media?parent=1858"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/categories?post=1858"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/tags?post=1858"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}